Tokyo, Japan

Rokuro Endo


Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 35(Granted Patents)


Location History:

  • Hiromachi, JP (1992 - 1993)
  • Tokyo, JP (1988 - 1999)

Company Filing History:


Years Active: 1988-1999

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Rokuro Endo: Innovator in Antibiotic Development

Introduction

Rokuro Endo is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotics. With a total of 8 patents to his name, Endo's work has had a substantial impact on medical science.

Latest Patents

Endo's latest patents focus on carbapenem derivatives, which are crucial in the fight against bacterial infections. One of his notable inventions is a compound of formula (I), where R¹ can be hydrogen, C₁-C₆ alkyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, or --C(=NH)R⁰, with R⁰ being hydrogen or C₁-C₆ alkyl. This compound is designed to be a potent antibiotic resistant to dehydropeptidase I. Another significant patent involves compounds of formula (I) where R² can be hydrogen or an optionally substituted aliphatic hydrocarbon or acylimidoyl. These compounds are also aimed at treating various microbial infections effectively.

Career Highlights

Rokuro Endo is associated with Sankyo Company, Limited, where he has been instrumental in advancing antibiotic research. His innovative approach and dedication to improving healthcare through effective medications have earned him recognition in the pharmaceutical industry.

Collaborations

Endo has collaborated with notable colleagues, including Isao Kawamoto and Masao Miyauchi. Their combined expertise has contributed to the successful development of new antibiotic therapies.

Conclusion

Rokuro Endo's contributions to antibiotic development highlight his role as a key innovator in the pharmaceutical field. His patents reflect a commitment to addressing critical health challenges through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…